These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26656867)

  • 1. A High-Content Imaging Screen for Cellular Regulators of β-Catenin Protein Abundance.
    Zeng X; Montoute M; Bee TW; Lin H; Kallal LA; Liu Y; Agarwal P; Wang D; Lu Q; Morrow D; Pope AJ; Wu Z
    J Biomol Screen; 2016 Mar; 21(3):260-8. PubMed ID: 26656867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
    Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
    Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice.
    Waaler J; Machon O; Tumova L; Dinh H; Korinek V; Wilson SR; Paulsen JE; Pedersen NM; Eide TJ; Machonova O; Gradl D; Voronkov A; von Kries JP; Krauss S
    Cancer Res; 2012 Jun; 72(11):2822-32. PubMed ID: 22440753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of β-Catenin Degradation-Competent Axin Puncta.
    Martino-Echarri E; Brocardo MG; Mills KM; Henderson BR
    PLoS One; 2016; 11(3):e0150484. PubMed ID: 26930278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer.
    Qu Y; Olsen JR; Yuan X; Cheng PF; Levesque MP; Brokstad KA; Hoffman PS; Oyan AM; Zhang W; Kalland KH; Ke X
    Nat Chem Biol; 2018 Jan; 14(1):94-101. PubMed ID: 29083417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signaling as a therapeutic target for cancer.
    Herbst A; Kolligs FT
    Methods Mol Biol; 2007; 361():63-91. PubMed ID: 17172707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Berberine potently attenuates intestinal polyps growth in ApcMin mice and familial adenomatous polyposis patients through inhibition of Wnt signalling.
    Zhang J; Cao H; Zhang B; Cao H; Xu X; Ruan H; Yi T; Tan L; Qu R; Song G; Wang B; Hu T
    J Cell Mol Med; 2013 Nov; 17(11):1484-93. PubMed ID: 24015932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes.
    Thorvaldsen TE; Pedersen NM; Wenzel EM; Schultz SW; Brech A; Liestøl K; Waaler J; Krauss S; Stenmark H
    Mol Cancer Res; 2015 Nov; 13(11):1487-501. PubMed ID: 26124443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-based assay for low- and high-scale screening of the Wnt/β-catenin signaling modulators.
    Mazur M; Bujak A; Matloka M; Janowska S; Gunerka P; Bojarski L; Stanczak A; Klejman A; Bednarek A; Lamparska-Przybysz M; Wieczorek M
    Anal Biochem; 2015 Apr; 475():56-67. PubMed ID: 25659657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer.
    Cheng X; Xu X; Chen D; Zhao F; Wang W
    Biomed Pharmacother; 2019 Feb; 110():473-481. PubMed ID: 30530050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the phosphorylation and nuclear import and export of β-catenin by APC and its cancer-related truncated form.
    Wang L; Liu X; Gusev E; Wang C; Fagotto F
    J Cell Sci; 2014 Apr; 127(Pt 8):1647-59. PubMed ID: 24496450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell growth in vitro and in vivo via downregulation of Wnt/Beta-catenin signaling.
    Song KS; Jing K; Kim JS; Yun EJ; Shin S; Seo KS; Park JH; Heo JY; Kang JX; Suh KS; Wu T; Park JI; Kweon GR; Yoon WH; Hwang BD; Lim K
    Pancreatology; 2011; 11(6):574-84. PubMed ID: 22213040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of broussochalcone a against colon and liver cancer cells by promoting destruction complex-independent β-catenin degradation.
    Shin S; Son Y; Liu KH; Kang W; Oh S
    Food Chem Toxicol; 2019 Sep; 131():110550. PubMed ID: 31163223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional inhibition of β-catenin-mediated Wnt signaling by intracellular VHH antibodies.
    Newnham LE; Wright MJ; Holdsworth G; Kostarelos K; Robinson MK; Rabbitts TH; Lawson AD
    MAbs; 2015; 7(1):180-91. PubMed ID: 25524068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous destabilization of β-catenin and Ras via targeting of the axin-RGS domain as a potential therapeutic strategy for colorectal cancer.
    Cha PH; Choi KY
    BMB Rep; 2016 Sep; 49(9):455-6. PubMed ID: 27470214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15.
    Huang X; Langelotz C; Hetfeld-Pechoc BK; Schwenk W; Dubiel W
    J Mol Biol; 2009 Aug; 391(4):691-702. PubMed ID: 19576224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
    Arend RC; Londoño-Joshi AI; Samant RS; Li Y; Conner M; Hidalgo B; Alvarez RD; Landen CN; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2014 Jul; 134(1):112-20. PubMed ID: 24736023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.